[1]
Baughman, R.P., Judson, M.A., Lower, E.E., Drent, M., Costabel, U., Flavin, S., Lo, K.H., Barnathan, E.S. and Sarcoidosis Investigators, on behalf of the 2016. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis, Vasculitis and Diffuse Lung Disease. 32, 4 (Jan. 2016), 289–295.